June 22, 2020 / 11:50 AM / 23 days ago

BRIEF-Exicure Presents Cavrotolimod (Ast-008) Clinical Data At AACR 2020 Virtual Meeting

June 22 (Reuters) - Exicure Inc:

* EXICURE PRESENTS CAVROTOLIMOD (AST-008) CLINICAL DATA AT AACR 2020 VIRTUAL MEETING

* EXICURE - CAVROTOLIMOD WAS WELL-TOLERATED

* EXICURE - NO CAVROTOLIMOD (AST-008)-RELATED SERIOUS ADVERSE EVENTS OR DOSE LIMITING TOXICITY HAVE BEEN REPORTED Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below